COVID-19 antibody therapeutics tracker: a global online database of antibody therapeutics for the prevention and treatment of COVID-19.

Antibody Therapeutics
Lifei YangMitchell Ho


Facing the COVID-19 global healthcare crisis, scientists worldwide are collaborating to develop prophylactic and therapeutic interventions against the disease. Antibody therapeutics hold enormous promise for the treatment of COVID-19. In March 2020, the Chinese Antibody Society, in collaboration with The Antibody Society, initiated the "COVID-19 Antibody Therapeutics Tracker" ("Tracker") ( program to track the antibody-based COVID-19 interventions in preclinical and clinical development globally. The data are collected from the public domain and verified by volunteers on an ongoing basis. Here, we present exploratory data analyses and visualization to demonstrate the latest trends of COVID-19 antibody development, based on data for over 150 research and development programs and molecules included in the "Tracker" as of 8 August 2020. We categorized the data mainly by their targets, formats, development status, developers and country of origin. Although details are limited in some cases, all of the anti-SARS-CoV-2 antibody candidates appear to target the viral spike protein (S protein), and most are full-length monoclonal antibodies. Most of the current COVID-19 antibody therapeutic ca...Continue Reading


Apr 12, 2003·The New England Journal of Medicine·Christian DrostenHans Wilhelm Doerr
Apr 12, 2003·The New England Journal of Medicine·Thomas G KsiazekUNKNOWN SARS Working Group
Oct 19, 2012·The New England Journal of Medicine·Ali M ZakiRon A M Fouchier
Nov 2, 2017·Cell Reports·Eileen M GeogheganChristopher B Buck
Jan 25, 2020·The New England Journal of Medicine·Na ZhuUNKNOWN China Novel Coronavirus Investigating and Research Team
Jan 30, 2020·The New England Journal of Medicine·Qun LiZijian Feng
Feb 23, 2020·Science·Daniel WrappJason S McLellan
Apr 1, 2020·The New England Journal of Medicine·Muthiah VaduganathanScott D Solomon
Apr 8, 2020·Journal of Medical Virology·Pan LuoJuan Li
May 6, 2020·Nature Communications·Chunyan WangBerend-Jan Bosch
Jun 9, 2020·BioRxiv : the Preprint Server for Biology·Dora PintoDavide Corti
Jul 9, 2020·BioRxiv : the Preprint Server for Biology·Leonid YurkovetskiyJeremy Luban

❮ Previous
Next ❯


Dec 16, 2020·MAbs·Marco TuccoriDaniele Focosi
Jan 21, 2021·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Manman LiuYangzhong Liu
Dec 31, 2020·Journal of Molecular Cell Biology·Liu Daisy LiuFei-Long Meng
Jan 7, 2021·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Bhavesh D KevadiyaHoward E Gendelman
Mar 9, 2021·Frontiers in Medicine·Candice Laverne HendricksMichael Sean Pepper
Mar 25, 2021·Biological Chemistry·Bernhard ValldorfStefan Zielonka
Apr 30, 2021·Antibody Therapeutics·Yaping Sun, Mitchell Ho
May 1, 2021·Viruses·Aeron C Hurt, Adam K Wheatley
May 1, 2021·Antibody Therapeutics·Donovan GuttieresStacy L Springs
Jun 1, 2021·Frontiers in Molecular Biosciences·Miao Mei, Xu Tan
Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Marco A Almaraz-GirónSandra L Castañón-Alonso
Jul 27, 2021·World Journal of Clinical Cases·Ceylan Polat, Koray Ergunay
Jul 29, 2021·Clinical Microbiology Reviews·Kaiming TaoRobert W Shafer
Apr 16, 2021·British Journal of Clinical Pharmacology·Jasmine DavdaPatrick F Smith
Sep 3, 2021·The Cochrane Database of Systematic Reviews·Nina KreuzbergerNicole Skoetz

❮ Previous
Next ❯

Software Mentioned

WPDatatable Plugin

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.